![](/img/cover-not-exists.png)
765 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE RESPONSE (RPCDBDR) TRIAL OF CTS-1027, AN INHIBITOR OF MATRIX METALLOPROTEASES (MMPS) IN PATIENTS WITH HCV WHO HAD FAILED PRIOR THERAPIES
P.J. Pockros, S.C. Gordon, A. McCullough, M. Charlton, N. Bzowej, J. Vierling, M. Bansal, B. Yoffe, G. Everson, M. Huyghe, A. Fox, S. Mento, O. Bohm, B. Plouffe, R. Cross, M. ShiffmanVolume:
52
Year:
2010
Language:
english
DOI:
10.1016/s0168-8278(10)60767-2
File:
PDF, 69 KB
english, 2010